Ex vivo drug sensitivity profiles of Plasmodium falciparum field isolates from Cambodia and Thailand, 2005 to 2010, determined by a histidine-rich protein-2 assay

[1] Desjardins RE(1979)Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique Antimicrob Agents Chemother 16 710-718

[2] Canfield CJ(1985)Antimalarial drug susceptibility testing of Plasmodium falciparum in Thailand using a microdilution radioisotope method Am J Trop Med Hyg 34 228-235

[3] Haynes JD(2002)Epidemiology of drug-resistant malaria Lancet Infect Dis 2 209-218

[4] Chulay JD(2004)A histidine-rich protein 2-based malaria drug sensitivity assay for field use Am J Trop Med Hyg 71 711-714

[5] Webster HK(2005)Simple histidine-rich protein 2 double-site sandwich enzyme-linked immunosorbent assay for use in malaria drug sensitivity testing Antimicrob Agents Chemother 49 3575-3577

[6] Boudreau EF(2008)Evidence of artemisinin-resistant malaria in western Cambodia NEJM 359 2619-2620

[7] Pavanand K(2011)WHO urges the phasing out of artemisinin based monotherapy for malaria to reduce resistance BMJ 342 d2793-4487

[8] Yongvanitchit K(2007)Large-scale malaria survey in Cambodia: novel insights on species distribution and risk factors Malar J 6 37-41

[9] Pang LW(2004)Nonisotopic, semiautomated plasmodium falciparum bioassay for measurement of antimalarial drug levels in serum or plasma Antimicrob Agents Chemother 48 4485-3601

[10] Wongsrichanalai C(2011)Anti-malarial drug sensitivity profile of western Kenya Plasmodium falciparum field isolates determined by a SYBR Green I in vitro assay, and molecular analysis Amer J Trop Med Hyg 85 34-8768

[1] Desjardins RE(1979)Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique Antimicrob Agents Chemother 16 710-718

[2] Canfield CJ(1985)Antimalarial drug susceptibility testing of Plasmodium falciparum in Thailand using a microdilution radioisotope method Am J Trop Med Hyg 34 228-235

[3] Haynes JD(2002)Epidemiology of drug-resistant malaria Lancet Infect Dis 2 209-218

[4] Chulay JD(2004)A histidine-rich protein 2-based malaria drug sensitivity assay for field use Am J Trop Med Hyg 71 711-714

[5] Webster HK(2005)Simple histidine-rich protein 2 double-site sandwich enzyme-linked immunosorbent assay for use in malaria drug sensitivity testing Antimicrob Agents Chemother 49 3575-3577

[6] Boudreau EF(2008)Evidence of artemisinin-resistant malaria in western Cambodia NEJM 359 2619-2620

[7] Pavanand K(2011)WHO urges the phasing out of artemisinin based monotherapy for malaria to reduce resistance BMJ 342 d2793-4487

[8] Yongvanitchit K(2007)Large-scale malaria survey in Cambodia: novel insights on species distribution and risk factors Malar J 6 37-41

[9] Pang LW(2004)Nonisotopic, semiautomated plasmodium falciparum bioassay for measurement of antimalarial drug levels in serum or plasma Antimicrob Agents Chemother 48 4485-3601

[10] Wongsrichanalai C(2011)Anti-malarial drug sensitivity profile of western Kenya Plasmodium falciparum field isolates determined by a SYBR Green I in vitro assay, and molecular analysis Amer J Trop Med Hyg 85 34-8768